ICU Volume 7 - Issue 3 - Autumn 2007 - News

Grant in the US of a Patent for Setting and Adjusting of a Cardiac Biventricular Pacemaker

LiDCO, the UK based, AIM-quoted cardiovascular monitoring company, announced that it has received confirmation of the approval of its US Patent application for a new method and apparatus for optimally adjusting a biventricular pacemaker – used for the treatment of congestive heart failure (CHF). The method involves the measurementof changes in certain haemodynamic parameters (arterial pulse pressure and stroke volume) that have been shown to reflect improvements in the heart’s pumping action (ventricular performance). Using the LiDCOplus Monitor these parameters are measured minimally invasively and beatto- beat.


www.lidco.com


Print as PDF
LiDCO, the UK based, AIM-quoted cardiovascular monitoringcompany, announced that it has received confirmation of the approval of its USPatent application f

No comment


Please login to leave a comment...

Highlighted Products